Etizolam
1Provenance card
the boundary, as counts
Sources
3919 with DOI
12 strong · 15 moderate · 12 weak
Compilations
12026-05-08T17:10:03.088Z
pipeline-v5 · prompt hash not recorded — run predates 2026-09
Decisions
34last ruled 2026-06-04
1 awaiting a ruling
Issued documents
42026-10-19T20:31:55.715Z
notice · info card · emergency
Searches
181 with no results
queries and counts on the build
Claims checked
115105 supported
105 supported · 10 not
Correspondence
0received
consent field ships in Phase 4
Edges
333
derivations recorded for this entity
Complete over 39 sources, 1 compilation, and 34 decisions.Not here: the private journal (never); 1 proposal awaiting a ruling (listed as pending only).Working material — drafts, discards, unsupported claims — is listed below and readable on the working page.Cite: psychedex.org/substances/etizolam/archive
Timeline
what happened, newest first — claims, searches and artifacts stay inside Build
- 2026-10-19issueIssued info_card
- 2026-10-02srcNotable Drug-Drug Interaction Between Etizolam and Itraconazole in Poor Metabolizers of Cytochrome P450 2C19
- 2026-10-02srcEffects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled study in patients with anxiety disorder
- 2026-10-02srcTesting Strategies and the Emergence of Designer Benzodiazepines
- 2026-10-02srcChanging characteristics in the 2020s of fatal 'novel' benzodiazepine toxicity cases in Australia
- 2026-10-02srcFentanyl concentrations in ligated femoral blood in the presence and absence of NPS benzodiazepine drugs - benzo-dope/fentanyl toxicity cases in Alberta, Canada
- 2026-10-02srcPostmortem distribution of etizolam in various autopsy samples using the surrogate analyte approach (SAA) method
- 2026-10-02srcEffect of hemoglobin on the concentration of etizolam in postmortem blood determined by liquid chromatography coupled with quadrupole-Orbitrap mass spectrometry
- 2026-10-02srcPrevalence and blood concentrations of benzodiazepines and opioids in opioid-positive death investigations in Ontario, Canada, from 2017 to 2021
- 2026-10-02srcEtizolam: A rapid review on pharmacology, non-medical use and harms
- 2026-10-02srcEtizolam and benzodiazepine induced blepharospasm
- 2026-10-02srcFemoral blood concentrations of the designer benzodiazepine etizolam in post-mortem cases
- 2026-10-02srcTwelve cases of drug-induced blepharospasm improved within 2 months of psychotropic cessation
- 2026-10-02srcIn Vitro Drug-Drug Interactions between Oxycodone and Commonly Co-Consumed Drugs in Rat and Human Liver Microsomes
- 2026-10-02src'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports
- 2026-10-02srcComparing Etizolam and Music Distraction on Inferior Alveolar Nerve Block Success in Patients With Symptomatic Irreversible Pulpitis: A Randomized Clinical Trial
- 2026-10-02srcAnxiolytics reduce residual dizziness after successful canalith repositioning maneuvers in benign paroxysmal positional vertigo
- 2026-10-02srcHigh-Dose Dependence and Cognitive Side Effects to Medical Prescription of Etizolam
- 2026-10-02srcDesigner Benzodiazepines: A Review of Toxicology and Public Health Risks
- 2026-10-02srcThe Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity.
- 2026-10-02srcMolecular and neurochemical evaluation of the effects of etizolam on GABAA receptors under normal and stress conditions.
- 2026-10-02srcEtizolam, an anti-anxiety agent, attenuates recurrence of chronic subdural hematoma--evaluation by computed tomography
- 2026-10-02srcEffects of thienodiazepine derivatives, etizolam and clotiazepam on the appearance of Fm theta
- 2026-10-02srcInhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism
- 2026-10-02srcPharmacokinetics and pharmacodynamics of etizolam are influenced by polymorphic CYP2C19 activity
- 2026-10-02srcEtizolam in the treatment of generalized anxiety disorder: a double-blind study versus placebo
- 2026-10-02srcA case of serotonin syndrome following minimum doses of sertraline (in patient also taking etizolam)
- 2026-10-02srcSingle and multiple dose pharmacokinetics of etizolam in healthy subjects
- 2026-10-02srcAn autopsy case of multiple psychotropic drug poisoning
- 2026-10-02srcEtizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study
- 2026-10-02srcEtizolam in the treatment of generalized anxiety disorder: a controlled clinical trial
- 2026-10-02srcEtizolam in the treatment of generalized anxiety disorder associated with depressive symptoms
- 2026-10-02srcEffects of thienodiazepine derivatives on human sleep as compared to those of benzodiazepine derivatives
- 2026-10-02srcHemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor
- 2026-10-02srcEtizolam UK Scheduling - Misuse of Drugs Act 1971 Amendment 2017
- 2026-10-02srcWHO Recommendation - Etizolam Schedule IV Convention on Psychotropic Substances
- 2026-10-02srcEtizolam Italy Prescribing Status and Medical Use
- 2026-10-02srcEtizolam permanent Schedule I placement in the United States
- 2026-10-02srcEtizolam Physical Properties - CAS 40054-69-1
- 2026-10-02srcEtizolam - History, Discovery, Yoshitomi Pharmaceutical Japan
- 2026-09-04issueIssued emergency
- 2026-09-04issueIssued info_card
- 2026-09-04issueIssued notice
- 2026-07-03proposaldependence · taper
- 2026-06-04proposal31 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
- 2026-06-04publicationPublication — backfill
- 2026-05-08revisionRevision 1
- 2026-05-08absenceSearched PubMed for "etizolam pharmacology mechanism action GABA receptor" — no results
- 2026-05-08genGeneration — pipeline-v5 · with 3 morepipeline-v5
- 2026-05-08rungeneration run
The same entries, as forms: six forms.